Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1D

NCT03632759 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: Liraglutide
DRUG: Golimumab

Sponsor

Carla Greenbaum, MD

Collaborators

[object Object]